Medtech
As the J.P. Morgan Healthcare Conference winds down for 2020, one of the big topics was the general lack of big deals. Still, there were some general trends and for today, some news.
As the J.P. Morgan Healthcare Conference enters its final day for 2020, a few topics have risen to the top.
Polyganics announced that it has obtained CE marking for LIQOSEAL®, its easy-to-use and innovative dural sealant patch, and will launch the device in Europe with immediate effect.
Polarean Imaging plc announces that the Company has delivered and installed its latest research unit order for a 9820 Xenon Polariser system from the University of Iowa Hospitals and Clinics (“UI Hospitals & Clinics”).
Pharma and life sciences companies bolster their leadership teams and boards with this week’s Movers & Shakers.
As a valued member of our BioSpace community, we are eager to hear more from you and other readers as we head into 2020. We want to know if you have grown in your career over the past year.
IBA, the world’s leading provider of solutions for the diagnosis and treatment of cancer, announces that it has sold RadioMed Corporation, IBA’s VISICOIL™ fiducial markers business, to IZI Medical Products LLC, a leading interventional medical device company in a deal that is worth between USD 14 and 16 million to IBA.
Latest funding caps year of groundbreaking milestones for transformative vascular access company; new capital will be used to meet rapidly growing hospital and patient demand
BioGenerator-backed company is first to manufacture digital health device in St. Louis
MagForce successfully hosted the second session of its practice-oriented, unique, multifaceted application training for the use of the NanoTherm therapy system in treating brain tumors
PRESS RELEASES